320
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation

, , &
Pages 741-747 | Received 06 Dec 2017, Accepted 31 Mar 2018, Published online: 24 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jenny Abrahamsson, Malin Sternby Eilard, Magnus Rizell, William Bennett & Fredrik Åberg. (2022) Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation. Scandinavian Journal of Gastroenterology 57:3, pages 325-332.
Read now
Eloi Chevallier, Thomas Jouve, Lionel Rostaing, Paolo Malvezzi & Johan Noble. (2021) pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Review of Clinical Pharmacology 14:1, pages 55-66.
Read now

Articles from other publishers (12)

Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang, Kyung-Suk Suh, Mamun Al Mahtab, Soek Siam Tan, Zaigham Abbas, Ananta Shresta, Shahinul Alam, Anil Arora, Ashish Kumar, Pravin Rathi, Ruveena Bhavani, Charles Panackel, Kuei Chuan Lee, Jun Li, Ming-Lung Yu, Jacob George, Tawesak Tanwandee, Sen-Yung Hsieh, Chee Chien Yong, Mohamed Rela, H. C. Lin, Masao Omata & Shiv Kumar Sarin. (2024) Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation. Hepatology International 18:2, pages 299-383.
Crossref
Sunil Taneja, Akash Roy & Ajay Duseja. (2023) NASH After Liver Transplantation: Impact of Immunosuppression. Journal of Clinical and Experimental Hepatology 13:5, pages 835-840.
Crossref
Yuan Pan, Yu-Xi Chen, Yao Lu, Yan-Yan Xie, Yi-Wen Xia & Dan Liang. (2022) Outcomes of Escalating Immunosuppressive Treatments for Recalcitrant Noninfectious Posterior Scleritis. Ophthalmology and Therapy 11:6, pages 2297-2307.
Crossref
Eleonora De Martin, Maria‐Carlota Londoño, Juliet Emamaullee, Jan Lerut, Jonathan Potts, Varuna Aluvihare, Michael Spiro, Dimitri Aristotle Raptis & Geoffrey McCaughan. (2022) The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations. Clinical Transplantation 36:10.
Crossref
Abraham Shaked, Bao-Li Loza, Elisabet Van Loon, Kim M. Olthoff, Weihua Guan, Pamala A. Jacobson, Andrew Zhu, Claire E. Fishman, Hui Gao, William S. Oetting, Ajay K. Israni, Giuliano Testa, James Trotter, Goran Klintmalm, Maarten Naesens, Sumeet K. Asrani & Brendan J. Keating. (2022) Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes. Nature Medicine 28:5, pages 999-1005.
Crossref
Ali R Chaitou, Surbhi Valmiki, Mrinaal Valmiki, Maria Zahid, Mohamed A Aid, Peter Fawzy & Safeera Khan. (2022) New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy. Cureus.
Crossref
Mariana Baldini Campos, Cínthia Minatel Riguetto, Ilka de Fátima Santana Ferreira Boin & Arnaldo MouraNetoNeto. (2022) Risk factors associated with diabetes after liver transplant. Archives of Endocrinology and Metabolism.
Crossref
Pan Kun-ming, Chen Can, Xu Qing, Wu Wei, Lv Qian-zhou & Li Xiao-yu. (2021) Calcineurin inhibitor–associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China. European Journal of Clinical Pharmacology 77:7, pages 961-969.
Crossref
Narendra S. Choudhary, Neeraj Saraf, Sanjiv Saigal & Arvinder S. Soin. (2021) Long-term Management of the Adult Liver Transplantation Recipients. Journal of Clinical and Experimental Hepatology 11:2, pages 239-253.
Crossref
Khurram Bari, Shimul A. Shah, Tiffany E. Kaiser, Robert M. Cohen, Nadeem Anwar, David Kleesattel & Kenneth E. Sherman. (2020) Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial. Liver Transplantation 26:11, pages 1430-1440.
Crossref
Nadav Mizrahi, Marius Braun, Tuvia Ben Gal, Dror Rosengarten, Mordechai Reuven Kramer & Alon Grossman. (2020) Post-transplant diabetes mellitus: incidence, predicting factors and outcomes. Endocrine 69:2, pages 303-309.
Crossref
Narendra S. Choudhary & Sanjiv Saigal. (2019) Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation. Journal of Clinical and Experimental Hepatology 9:5, pages 619-624.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.